STAAR Surgical Company
STAA
$18.84
$0.452.45%
NASDAQ
| 01/02/2026 | 09/26/2025 | 06/27/2025 | 03/28/2025 | 12/27/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.08% | 6.93% | -55.23% | -44.94% | -35.82% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.08% | 6.93% | -55.23% | -44.94% | -35.82% |
| Cost of Revenue | -18.74% | -16.15% | -44.05% | -10.64% | 11.28% |
| Gross Profit | 38.21% | 13.71% | -58.17% | -54.12% | -47.88% |
| SG&A Expenses | -8.69% | -12.53% | -13.54% | -1.70% | 30.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -10.54% | -15.22% | -20.75% | -2.89% | 19.23% |
| Operating Income | 60.84% | 326.08% | -306.08% | -1,464.98% | -334.83% |
| Income Before Tax | 31.92% | 42.79% | -350.77% | -2,364.31% | -320.79% |
| Income Tax Expenses | -160.17% | 211.61% | -408.05% | -124.38% | -34.92% |
| Earnings from Continuing Operations | 46.51% | -10.98% | -327.84% | -1,523.57% | -541.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 46.51% | -10.98% | -327.84% | -1,523.57% | -541.31% |
| EBIT | 60.84% | 326.08% | -306.08% | -1,464.98% | -334.83% |
| EBITDA | 65.06% | 253.01% | -268.18% | -3,203.68% | -294.88% |
| EPS Basic | 47.04% | -11.74% | -326.03% | -1,508.49% | -537.26% |
| Normalized Basic EPS | 71.44% | 86.36% | -298.33% | -1,324.38% | -298.66% |
| EPS Diluted | 47.04% | -10.50% | -326.67% | -1,471.43% | -537.26% |
| Normalized Diluted EPS | 71.44% | 84.95% | -301.08% | -1,324.38% | -300.42% |
| Average Basic Shares Outstanding | 1.00% | 0.88% | 0.80% | 0.89% | 0.92% |
| Average Diluted Shares Outstanding | 1.00% | 1.64% | -0.58% | 0.89% | 0.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |